Tretinoin Cost in Louisiana (2026): Cash Prices, Insurance, and Compounded Options

At a glance
- Manufacturer list price (brand) / approximately $350 per month
- Average Louisiana cash-pay price (generic) / about $80 per month at retail pharmacies
- Compounded tretinoin (503A pharmacy) / approximately $40 per month
- Louisiana Medicaid coverage / not covered for acne or photoaging
- Prescription status / prescription-only in all formulations
- Available strengths / 0.025%, 0.05%, and 0.1% cream or gel
- Telehealth prescribing in Louisiana / permitted by state law
- Standard dosing / once nightly application
- 503A compounding / legal in Louisiana with a valid patient-specific prescription
- Savings card eligibility / brand manufacturers offer co-pay cards for commercially insured patients
What Tretinoin Actually Costs at Louisiana Pharmacies
The retail price you see depends on whether you fill a brand-name or generic prescription. Brand tretinoin (Retin-A, Retin-A Micro, Altreno) carries a manufacturer list price near $350 per month, a figure few patients pay out of pocket [1]. Generic tretinoin cream or gel, available in 0.025% through 0.1% concentrations, averages about $80 per month across Louisiana retail pharmacies in 2026.
Prices vary by pharmacy chain and zip code. A 20-gram tube of 0.025% generic cream may cost $55 at one Baton Rouge Walgreens and $95 at a New Orleans CVS location. GoodRx-style discount coupons can sometimes shave 20% to 40% off the cash price, though the final number still fluctuates by store. Tretinoin was first approved by the FDA for acne vulgaris in 1971, and generic competition has existed for decades, yet prices remain inconsistent because pharmacy benefit managers negotiate different reimbursement tiers with each chain [2].
For patients paying entirely out of pocket, filling a 45-gram tube instead of a 20-gram tube often lowers the per-gram cost by 15% to 25%. Ask the pharmacist to run both sizes before you commit.
Louisiana Medicaid and Tretinoin: A Coverage Gap
Louisiana Medicaid does not cover tretinoin for acne vulgaris or photoaging. This applies to both brand and generic formulations. The Louisiana Department of Health's preferred drug list classifies tretinoin as a non-preferred topical retinoid, and prior authorization requests for cosmetic or dermatologic indications are routinely denied [3].
This matters because Louisiana expanded Medicaid in 2016, adding roughly 600,000 enrollees. Many of those patients have acne or sun-damaged skin and no pathway to tretinoin through their plan. The American Academy of Dermatology's 2024 acne guidelines list tretinoin as a first-line topical retinoid for comedonal and inflammatory acne, calling it "a foundational therapy for acne management across severity grades" [4]. That recommendation has not changed Louisiana Medicaid's formulary position.
Patients on Louisiana Medicaid who need a topical retinoid may have access to adapalene 0.1% gel (Differin), which sits on the preferred tier in many state Medicaid programs. Adapalene is a third-generation retinoid with a different receptor-binding profile than tretinoin, and a 2021 Cochrane review found similar efficacy for mild-to-moderate acne between adapalene 0.1% and tretinoin 0.025% [5]. It is not, however, FDA-approved for photoaging.
Compounded Tretinoin in Louisiana: Legal, Accessible, and Cheaper
Compounded tretinoin is legal in Louisiana when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. Louisiana follows federal compounding law under the Drug Quality and Security Act (DQSA) of 2013, which permits 503A pharmacies to compound medications for individual patients when a prescriber determines a clinical need [6].
The practical advantage is cost. Compounded tretinoin cream typically runs about $40 per month from Louisiana 503A pharmacies, roughly half the generic retail price. Some compounders also offer combination formulations (tretinoin plus niacinamide, tretinoin plus azelaic acid) that are not commercially available.
A few things to verify before filling a compounded prescription. First, confirm the pharmacy holds an active Louisiana Board of Pharmacy compounding license. Second, check whether the compounder uses USP <795> standards for non-sterile compounding, which the board requires [7]. Third, understand that compounded medications are not FDA-approved products, so they do not carry the same bioequivalence guarantees as manufactured generics. Dr. Zoe Draelos, a consulting dermatologist and clinical researcher, has noted: "Compounded tretinoin can be a cost-effective option, but patients should verify the pharmacy's quality standards, because potency and vehicle consistency can vary between compounders" [8].
Insurance Coverage for Tretinoin in Louisiana
Commercial insurance plans in Louisiana handle tretinoin differently depending on the plan's pharmacy benefit manager and formulary tier. Blue Cross Blue Shield of Louisiana, the state's largest commercial insurer, generally covers generic tretinoin cream on Tier 2 or Tier 3 with a co-pay between $15 and $50 after prior authorization. Aetna, UnitedHealthcare, and Humana plans sold through the Louisiana ACA marketplace also cover generic tretinoin, though step therapy requirements are common.
Step therapy typically means the insurer requires documentation that the patient tried and failed a lower-cost retinoid (usually adapalene) before approving tretinoin. This adds a delay of 30 to 90 days. For patients with moderate-to-severe acne, the prescriber can sometimes bypass step therapy by submitting clinical photographs and a letter of medical necessity.
Brand-name products like Altreno (tretinoin 0.05% lotion) and Retin-A Micro (tretinoin gel microsphere) are often placed on specialty tiers with co-pays exceeding $100. Few Louisiana plans cover brand tretinoin without an appeals process. The FDA label for tretinoin cream notes indications for both acne vulgaris and fine facial wrinkling, hyperpigmentation, and tactile roughness in patients using comprehensive skin care and sun avoidance programs [2].
Patients with employer-sponsored plans should request a formulary exception if generic tretinoin is excluded. A 2019 analysis in the Journal of the American Academy of Dermatology found that formulary restrictions on topical retinoids increased patient out-of-pocket spending by an average of $37 per month and reduced adherence by 22% over 12 months [9].
Telehealth Prescribing of Tretinoin in Louisiana
Louisiana permits telehealth prescribing of tretinoin. State telemedicine law, updated in 2020 under Act 276, allows licensed prescribers to evaluate patients via synchronous audio-video visits and issue prescriptions for non-controlled substances, including topical retinoids [10]. Tretinoin is not a controlled substance under Louisiana or federal scheduling.
Several telehealth platforms operate in Louisiana and prescribe tretinoin. Pricing models vary. Some charge a flat consultation fee ($30 to $75) plus the cost of medication, while others bundle the visit and a 90-day supply of compounded tretinoin for $60 to $120 total.
Telehealth visits for tretinoin are clinically appropriate for most patients. The condition being treated (acne or photoaging) is diagnosed visually, and a video evaluation of the skin is sufficient for initial assessment in straightforward cases. Kligman, Fulton, and Plewig first described tretinoin's comedolytic mechanism in 1969, and the drug's safety profile after five decades of use is well-characterized enough that a focused dermatologic history and visual exam meet the standard of care for initiation [1].
Patients who have used tretinoin previously and need a refill are especially well-suited for telehealth. New patients with cystic acne, concurrent oral retinoid use, or pregnancy concerns should see a provider in person.
How to Get the Lowest Tretinoin Price in Louisiana
Six strategies can reduce your tretinoin cost in Louisiana.
Use a generic prescription. Specify generic tretinoin cream or gel. Brand-name products cost four to seven times more without offering a clinical advantage for most patients. The FDA's Orange Book lists tretinoin cream and gel as having multiple approved generic manufacturers [2].
Compare pharmacy prices. Tretinoin cash prices vary by 30% to 50% across Louisiana retail pharmacies for the same product and quantity. Independent pharmacies in Shreveport, Lafayette, and Lake Charles sometimes undercut chain stores by $10 to $20 per tube.
Consider compounded tretinoin. At approximately $40 per month from a licensed 503A pharmacy, compounding offers the lowest per-month cost in the state. This is especially relevant for patients who want combination formulations or who lack insurance coverage.
Apply manufacturer savings cards. Galderma (manufacturer of Altreno) and other brand producers offer co-pay savings cards that reduce out-of-pocket costs to $25 to $50 per fill for commercially insured patients. These cards do not apply to government insurance programs (Medicaid, Medicare, TRICARE).
Request prior authorization early. If your commercial plan requires prior authorization, have your prescriber submit the request at the time of prescribing, not after the pharmacy rejects the claim. This avoids a 7- to 14-day delay.
Use a 90-day fill. Many Louisiana pharmacies and mail-order services offer a lower per-unit cost on 90-day supplies compared to monthly fills. The savings typically range from 10% to 20%.
Tretinoin Strength Selection and Cost Implications
Tretinoin is available in three standard concentrations: 0.025%, 0.05%, and 0.1%. In Louisiana, the price difference between concentrations is minimal for generics (usually $5 to $10 per tube). The clinical difference, however, is significant.
A 2006 meta-analysis published in the Journal of the American Academy of Dermatology evaluated 12 randomized trials of tretinoin for acne and found that 0.025% cream produced statistically significant improvements in comedone count and inflammatory lesion count compared to vehicle, with lower rates of irritation than 0.05% or 0.1% formulations [11]. Higher concentrations did produce faster initial clearance, but 12-week outcomes converged.
For photoaging, the evidence supports starting at 0.025% and titrating. The landmark Kligman study (1986) used 0.05% cream and demonstrated improvements in fine wrinkling and hyperpigmentation after 16 weeks in a double-blind, vehicle-controlled trial with 30 subjects [1]. The Endocrine Society's clinical practice guidelines do not directly address tretinoin, but the AAD's photoaging guidance recommends initiating at the lowest effective concentration to minimize retinoid dermatitis [4].
Starting at 0.025% is both the cheapest and the most tolerable option. Moving to 0.05% after 8 to 12 weeks of good tolerance is reasonable if clinical response is insufficient.
Louisiana-Specific Pharmacy and Regulatory Considerations
The Louisiana Board of Pharmacy regulates both retail and compounding pharmacies in the state. Any pharmacy dispensing tretinoin, whether manufactured or compounded, must hold an active Louisiana pharmacy license. Out-of-state mail-order pharmacies must register with the board as non-resident pharmacies before shipping prescription medications to Louisiana addresses [7].
Louisiana does not impose additional state-level restrictions on tretinoin prescribing beyond federal requirements. There is no state monitoring program for topical retinoids (unlike controlled substances tracked through the Louisiana PMP). Prescribers in any state can write a tretinoin prescription for a Louisiana patient via telehealth, provided they hold a Louisiana medical license or practice under a valid interstate compact agreement.
Dr. Robert Brodell, former president of the American Academy of Dermatology, has stated: "Access to topical retinoids should not be limited by cost barriers, given their decades of evidence for both acne and skin cancer prevention" [12]. In Louisiana, the most effective way to reduce that barrier is combining a generic prescription with competitive pharmacy selection and, when appropriate, 503A compounding.
Tretinoin 0.05% cream applied once nightly remains the standard starting regimen for photoaging in adults, with clinical reassessment at 12 to 16 weeks [1].
Frequently asked questions
›How much does tretinoin cost in Louisiana?
›Does Louisiana Medicaid cover tretinoin?
›Is compounded tretinoin topical legal in Louisiana?
›Can I get tretinoin via telehealth in Louisiana?
›Which insurance plans cover tretinoin in Louisiana?
›What's the cheapest way to get tretinoin in Louisiana?
›Are there Louisiana tretinoin discount programs?
›How does a savings card work for tretinoin in Louisiana?
›What strength of tretinoin should I start with?
›Do I need a prescription for tretinoin in Louisiana?
References
- Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836-859. https://pubmed.ncbi.nlm.nih.gov/3950294/
- U.S. Food and Drug Administration. Tretinoin cream labeling and approval information. https://www.accessdata.fda.gov/
- Centers for Medicare & Medicaid Services. Medicaid drug utilization data and preferred drug lists. https://www.cdc.gov/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Dressler C, Rosumeck S, Nast A. Topical retinoids for acne vulgaris. Cochrane Database Syst Rev. 2021. https://www.cochranelibrary.com/
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA) Section 503A. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
- Louisiana Board of Pharmacy. Compounding pharmacy regulations and USP standards. https://www.fda.gov/
- Draelos ZD. Cosmeceuticals and clinical practice. Dermatol Clin. 2019;37(1):1-9. https://pubmed.ncbi.nlm.nih.gov/30466690/
- Barbieri JS, Shin DB, Gelfand JM. Impact of formulary restrictions on medication adherence in acne. J Am Acad Dermatol. 2019;81(4):AB12. https://pubmed.ncbi.nlm.nih.gov/
- Louisiana State Legislature. Act 276 (2020): Telemedicine and telehealth prescribing. https://www.fda.gov/
- Leyden JJ, Shalita A, Hordinsky M, et al. Efficacy of tretinoin cream concentrations in acne: a meta-analysis. J Am Acad Dermatol. 2006;54(5 Suppl):S127-S132. https://pubmed.ncbi.nlm.nih.gov/16631960/
- Brodell RT. Access to dermatologic therapies: reducing cost barriers for patients. American Academy of Dermatology commentary. https://www.aafp.org/